Cargando…

Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study

BACKGROUND: Considering the limited accuracy of clinical examination for early diagnosis of rheumatic heart disease (RHD), echocardiography has emerged as an important epidemiological tool. The ideal setting for screening is yet to be defined. We aimed to evaluate the prevalence and pattern of laten...

Descripción completa

Detalles Bibliográficos
Autores principales: Nascimento, Bruno R., Sable, Craig, Nunes, Maria Carmo P., Diamantino, Adriana C., Oliveira, Kaciane K. B., Oliveira, Cassio M., Meira, Zilda Maria A., Castilho, Sandra Regina T., Santos, Júlia P. A., Rabelo, Letícia Maria M., Lauriano, Karlla C. A., Carmo, Gabriel A. L., Tompsett, Allison, Ribeiro, Antonio Luiz P., Beaton, Andrea Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850205/
https://www.ncbi.nlm.nih.gov/pubmed/29444774
http://dx.doi.org/10.1161/JAHA.117.008039
_version_ 1783306190565933056
author Nascimento, Bruno R.
Sable, Craig
Nunes, Maria Carmo P.
Diamantino, Adriana C.
Oliveira, Kaciane K. B.
Oliveira, Cassio M.
Meira, Zilda Maria A.
Castilho, Sandra Regina T.
Santos, Júlia P. A.
Rabelo, Letícia Maria M.
Lauriano, Karlla C. A.
Carmo, Gabriel A. L.
Tompsett, Allison
Ribeiro, Antonio Luiz P.
Beaton, Andrea Z.
author_facet Nascimento, Bruno R.
Sable, Craig
Nunes, Maria Carmo P.
Diamantino, Adriana C.
Oliveira, Kaciane K. B.
Oliveira, Cassio M.
Meira, Zilda Maria A.
Castilho, Sandra Regina T.
Santos, Júlia P. A.
Rabelo, Letícia Maria M.
Lauriano, Karlla C. A.
Carmo, Gabriel A. L.
Tompsett, Allison
Ribeiro, Antonio Luiz P.
Beaton, Andrea Z.
author_sort Nascimento, Bruno R.
collection PubMed
description BACKGROUND: Considering the limited accuracy of clinical examination for early diagnosis of rheumatic heart disease (RHD), echocardiography has emerged as an important epidemiological tool. The ideal setting for screening is yet to be defined. We aimed to evaluate the prevalence and pattern of latent RHD in schoolchildren (aged 5–18 years) and to compare effectiveness of screening between public schools, private schools, and primary care centers in Minas Gerais, Brazil. METHODS AND RESULTS: The PROVAR (Rheumatic Valve Disease Screening Program) study uses nonexperts and portable and handheld devices for RHD echocardiographic screening, with remote interpretation by telemedicine, according to the 2012 World Heart Federation criteria. Compliance with study consent and prevalence were compared between different screening settings, and variables associated with RHD were analyzed. In 26 months, 12 048 students were screened in 52 public schools (n=10 901), 2 private schools (n=589), and 3 primary care centers (n=558). Median age was 12.9 years, and 55.4% were girls. Overall RHD prevalence was 4.0% borderline (n=486) and 0.5% definite (n=63), with statistically similar rates between public schools (4.6%), private schools (3.5%), and primary care centers (4.8%) (P=0.24). The percentage of informed consents signed was higher in primary care centers (84.4%) and private schools (66.9%) compared with public schools (38.7%) (P<0.001). Prevalence was higher in children ≥12 years (5.3% versus 3.1%; P<0.001) and girls (4.9% versus 4.0%; P=0.02). Only age (odds ratio, 1.12; 95% confidence interval, 1.09–1.17; P<0.001) was independently associated with RHD. CONCLUSIONS: RHD screening in primary care centers seems to achieve higher coverage rates. Prevalence among schoolchildren is significantly high, with rates higher than expected in private schools of high‐income areas. These data are important for the formulation of public policies to confront RHD.
format Online
Article
Text
id pubmed-5850205
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58502052018-03-21 Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study Nascimento, Bruno R. Sable, Craig Nunes, Maria Carmo P. Diamantino, Adriana C. Oliveira, Kaciane K. B. Oliveira, Cassio M. Meira, Zilda Maria A. Castilho, Sandra Regina T. Santos, Júlia P. A. Rabelo, Letícia Maria M. Lauriano, Karlla C. A. Carmo, Gabriel A. L. Tompsett, Allison Ribeiro, Antonio Luiz P. Beaton, Andrea Z. J Am Heart Assoc Original Research BACKGROUND: Considering the limited accuracy of clinical examination for early diagnosis of rheumatic heart disease (RHD), echocardiography has emerged as an important epidemiological tool. The ideal setting for screening is yet to be defined. We aimed to evaluate the prevalence and pattern of latent RHD in schoolchildren (aged 5–18 years) and to compare effectiveness of screening between public schools, private schools, and primary care centers in Minas Gerais, Brazil. METHODS AND RESULTS: The PROVAR (Rheumatic Valve Disease Screening Program) study uses nonexperts and portable and handheld devices for RHD echocardiographic screening, with remote interpretation by telemedicine, according to the 2012 World Heart Federation criteria. Compliance with study consent and prevalence were compared between different screening settings, and variables associated with RHD were analyzed. In 26 months, 12 048 students were screened in 52 public schools (n=10 901), 2 private schools (n=589), and 3 primary care centers (n=558). Median age was 12.9 years, and 55.4% were girls. Overall RHD prevalence was 4.0% borderline (n=486) and 0.5% definite (n=63), with statistically similar rates between public schools (4.6%), private schools (3.5%), and primary care centers (4.8%) (P=0.24). The percentage of informed consents signed was higher in primary care centers (84.4%) and private schools (66.9%) compared with public schools (38.7%) (P<0.001). Prevalence was higher in children ≥12 years (5.3% versus 3.1%; P<0.001) and girls (4.9% versus 4.0%; P=0.02). Only age (odds ratio, 1.12; 95% confidence interval, 1.09–1.17; P<0.001) was independently associated with RHD. CONCLUSIONS: RHD screening in primary care centers seems to achieve higher coverage rates. Prevalence among schoolchildren is significantly high, with rates higher than expected in private schools of high‐income areas. These data are important for the formulation of public policies to confront RHD. John Wiley and Sons Inc. 2018-02-14 /pmc/articles/PMC5850205/ /pubmed/29444774 http://dx.doi.org/10.1161/JAHA.117.008039 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Nascimento, Bruno R.
Sable, Craig
Nunes, Maria Carmo P.
Diamantino, Adriana C.
Oliveira, Kaciane K. B.
Oliveira, Cassio M.
Meira, Zilda Maria A.
Castilho, Sandra Regina T.
Santos, Júlia P. A.
Rabelo, Letícia Maria M.
Lauriano, Karlla C. A.
Carmo, Gabriel A. L.
Tompsett, Allison
Ribeiro, Antonio Luiz P.
Beaton, Andrea Z.
Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
title Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
title_full Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
title_fullStr Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
title_full_unstemmed Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
title_short Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
title_sort comparison between different strategies of rheumatic heart disease echocardiographic screening in brazil: data from the provar (rheumatic valve disease screening program) study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850205/
https://www.ncbi.nlm.nih.gov/pubmed/29444774
http://dx.doi.org/10.1161/JAHA.117.008039
work_keys_str_mv AT nascimentobrunor comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT sablecraig comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT nunesmariacarmop comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT diamantinoadrianac comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT oliveirakacianekb comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT oliveiracassiom comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT meirazildamariaa comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT castilhosandrareginat comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT santosjuliapa comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT rabeloleticiamariam comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT laurianokarllaca comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT carmogabrielal comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT tompsettallison comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT ribeiroantonioluizp comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT beatonandreaz comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy
AT comparisonbetweendifferentstrategiesofrheumaticheartdiseaseechocardiographicscreeninginbrazildatafromtheprovarrheumaticvalvediseasescreeningprogramstudy